Inhibitors
- New4-Hydroxynonenal [orb1089322]
[75899-68-2]
156.22214
C9H16O2
CCCCCC(/C=C/C=O)O
100 mg, 250 mg, 1 g - NewPitstop 2 [orb1089323]
[1419320-73-2]
473.36
C20H13BrN2O3S2
C(S(NC1=NC(=O)/C(=C/C2=CC=C(Br)C=C2)/S1)(=O)=O)1=C2C(C=CC=C2)=CC=C1
100 mg, 250 mg, 1 g - NewCDK9-IN-8 [orb1089324]
[2105956-51-0]
569.629289627075
C31H32FN7O3
FC1C=CC(=CC=1)NC(C1(C(NC2C=CC(=CC=2)NC2=NC=C3C=C(C(N(C)C)=O)N(C3=N2)C2CCCC2)=O)CC1)=O
100 mg, 250 mg, 1 g - NewBSJ-4-116 [orb1089325]
[2519823-34-6]
837.3839
C40H49CLN8O8S
ClC1=C([H])N=C(N=C1N([H])C1=C([H])C([H])=C([H])C([H])=C1S(C([H])(C([H])([H])[H])C([H])([H])[H])(=O)=O)N([H])[C@]1([H])C([H])([H])C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(C([H])([H])OC2=C([H])C([H])=C([H])C3C(N(C(C=32)=O)C2([H])C(N([H])C(C([H])([H])C2([H])[H])=O)=O)=O)=O)C1([H])[H]
100 mg, 250 mg, 1 g - NewWM3835 [orb1089326]
[2229025-70-9]
400.4244
C20H17FN2O4S
CC1=CC(C2=CC=CC=C2)=CC(C(NNS(=O)(C3=CC(O)=CC=C3)=O)=O)=C1F
100 mg, 250 mg, 1 g - NewARV-110 [orb1089327]
[2222112-77-6]
812.29
C41H43ClFN9O6
O=C(C1=NN=C(N2CCC(CN3CCN(C4=CC5=C(C(N(C(CC6)C(NC6=O)=O)C5=O)=O)C=C4F)CC3)CC2)C=C1)N[C@H]7CC[C@H](OC8=CC=C(C#N)C(Cl)=C8)CC7
10 mM * 1 mL in DMSO, 100 mg, 250 mg, 1 g - NewBOS172722 [orb1089328]
[1578245-44-9]
446.559
C24H30N8O
C(NC1=CC=C(C2N(C)C=NN=2)C=C1OCC)1=NC=C2C=C(C)N=C(NCC(C)(C)C)C2=N1
10 mM * 1 mL in DMSO, 100 mg, 250 mg, 1 g - NewCentrinone [orb1089329]
[1798871-30-3]
633.65
C26H25F2N7O6S2
CC1=CC(=NN1)NC2=NC(=NC(=C2OC)N3CCOCC3)SC4=C(C=C(C=C4)S(=O)(=O)CC5=C(C(=CC=C5)[N+](=O)[O-])F)F
100 mg, 250 mg, 1 g - NewParsaclisib hydrochloride [orb1089330]
[1995889-48-9]
469.34
C20H23Cl2FN6O2
CCOC1=C([C@@H](C2)CNC2=O)C(F)=C(Cl)C=C1[C@@H](N3C4=NC=NC(N)=C4C(C)=N3)C.[H]Cl
100 mg - NewCC-885 [orb1089331]
[1010100-07-8]
440.9
C22H21ClN4O4
N(C1=CC=C(C)C(Cl)=C1)C(NCC1C=CC2=C(C=1)CN(C1CCC(=O)NC1=O)C2=O)=O
100 mg, 250 mg, 1 g